After COVID-19 shutdowns disrupted cancer screenings on a wide scale last year, radiation oncologists are beginning to witness the ill effects. About two-thirds (66%) of such professionals said they’re now seeing new patients presenting with more advanced-stage cancers. Another 73% said physicians in their practice have noticed that patients are…
The agency is looking to lift the longstanding NCD that restricts patients to one amyloid-detecting positron emission tomography exam in their lifetime.
Payment cuts in Medicare, rising costs and administrative burdens all are pushing providers to seek sales, the AMA said Wednesday.
Imaging advocates blasted the proposal shortly after its release, saying it’s “unconscionable that radiology is again on the chopping block.”
When matched by gender and career length, nonemergency rads are nearly twice as likely to be promoted to associate professor.
Bayer AG’s former CEO is joining the startup’s board, expressing excitement about the prospect of using the platform to develop new drugs.
The nation’s largest imaging group has hired Barclays, hoping to raise “preferred equity” with a portion of its debts coming due in the next 2 years.
The Paris, France-based artificial intelligence developer will use the money to expand its product portfolio and headcount.
The Germany-based corporation said this is the “only contrast agent approved for this indication” in America.
Other imaging-related startup companies recently raising $4.9M or more include Altis Labs, BrainTale, Leadoptik and Hypervision Surgical.
The boost comes after the Los Angeles-based imaging center chain recently closed a $259M public stock offering, with a sizable chunk earmarked for expansion initiatives.
